rfhg_228387.1

Basic information about the TSS

---

TSS ID: rfhg_228387.1 Species: human Chr: chr22		Start: 24555685 End: 24555687 Strand: -
Source datasets	DBTSS
Protocol	TSS-seq
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3357771,EH38E2153636)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC002924:57 GeneID: 83606 HGNC/MGI_ID: HGNC:14237 UniProt_ID: Nearer transcript ids and distances: ENST00000407973.2:-172 NM_001284251.2:-207 NM_001284252.2:-207 NM_001284253.2:-207 NR_104286.2:-207 ENST00000621833.4:-248 ENST00000404664.7:-248 AK098754:-248 BC070109:378 view more...

Gene_name: guanylyl cyclase domain containing 1 Gene_symbol: GUCD1 Gene_synonyms: LLN4 MGC1842 Gene_source: HGNC:14237

TATA-Box annotation

---

Distance to TSS:	36
Nearest PromoterID:	NR_103819
Entrez ID:	6634
Nearest Unigene:	Hs.356549
Nearest Refseq:	NM_004175
Nearest Ensembl:	ENSG00000100028
Gene Name:	guanylyl cyclase domain containing 1
Gene Alias:	SMD3|Sm-D3
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GUCD1 p2@GUCD1 p3@GUCD1 p4@GUCD1 p5@GUCD1
Sample		p1@GUCD1	p2@GUCD1	p3@GUCD1	p4@GUCD1	p5@GUCD1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	7.40	14.81	4.29	2.34	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.70	15.38	3.03	3.24	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.91	18.52	2.51	3.28	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	6.03	16.01	3.74	2.29	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	7.20	14.17	4.05	2.25	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	5.04	14.73	3.29	2.33	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.68	12.64	1.53	2.61	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	6.78	10.17	2.42	1.70	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	9.62	13.25	3.42	2.14	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	9.85	9.85	4.64	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.94	8.49	1.62	2.83	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	14.64	10.57	2.44	2.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.31	2.10	2.10	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	17.14	2.71	1.65	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	11.42	0.88	1.98	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	10.81	3.27	0.75	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.29	2.84	1.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.81	3.37	2.11	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	6.93	1.60	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.24	2.26	1.50	0.15	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.16	2.54	2.14	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.77	2.59	1.90	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	12.54	2.59	1.55	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	10.68	2.91	0.73	0.49	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	13.42	2.06	1.81	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.50	1.58	1.90	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.64	3.85	0.00	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	12.26	1.65	1.41	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.66	2.10	1.29	0.32	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.58	1.27	1.45	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	14.86	2.30	0.84	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	11.92	2.54	0.98	0.39	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.82	1.90	2.32	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.91	2.31	1.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	17.58	1.68	0.93	0.37	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	15.90	3.07	0.77	0.38	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.47	2.25	0.61	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	15.51	3.43	0.60	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	10.80	2.16	1.62	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	16.32	2.88	0.96	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	20.70	2.59	1.88	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.95	1.90	1.46	0.44	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	21.30	2.32	1.90	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.26	4.55	1.92	1.57	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	14.25	3.41	2.01	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	15.12	2.79	1.16	1.16	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	19.91	3.84	0.96	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	17.29	4.17	2.09	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	17.00	2.63	1.91	1.44	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	19.82	3.64	1.42	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	14.55	2.87	2.46	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	18.46	6.45	2.67	1.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	15.97	5.68	1.42	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	17.56	7.29	2.98	1.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	5.03	2.52	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.73	3.21	2.76	1.84	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	14.26	9.08	3.24	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	22.16	3.53	1.61	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	10.06	5.03	1.26	1.26	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	12.69	2.82	2.82	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	17.38	3.93	0.56	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.17	3.18	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	10.53	5.10	2.04	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	24.69	9.42	1.95	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	16.33	5.32	1.77	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	16.58	3.41	0.98	0.98	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.40	3.47	0.99	1.49	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.91	5.16	1.41	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.26	5.63	1.66	1.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	16.09	2.47	1.24	0.93	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	15.90	7.64	0.00	0.92	0.00
Adipocyte - breast, donor1	11376-118A8	15.52	2.06	0.79	0.95	0.16
Adipocyte - breast, donor2	11327-117E4	20.05	2.25	0.32	0.64	0.80
Adipocyte - omental, donor1	11473-119C6	17.30	2.67	1.02	0.38	0.00
Adipocyte - omental, donor2	11474-119C7	9.72	2.99	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	14.74	2.34	1.34	1.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	15.31	3.19	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	1.10	0.00	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	20.77	1.35	0.45	0.90	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	38.93	2.95	1.04	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	27.38	3.13	1.76	1.37	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	11.32	4.38	0.51	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	15.05	3.35	1.67	0.84	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	17.63	1.76	1.18	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	35.07	3.70	0.97	0.72	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	20.98	4.52	0.65	0.97	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	19.19	3.20	0.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	24.48	2.23	0.56	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	30.78	3.74	1.25	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	20.60	4.77	0.25	0.75	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	20.29	2.95	1.31	1.31	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	19.18	1.83	0.30	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	13.48	7.29	1.55	2.21	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	19.36	9.32	1.79	2.15	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	2.40	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	13.67	5.76	3.42	1.98	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	0.00	1.67	5.02	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	21.57	4.93	1.64	1.03	0.21
Anulus Pulposus Cell, donor1	11248-116E6	18.77	2.17	3.20	0.34	0.69
Anulus Pulposus Cell, donor2	11463-119B5	17.63	2.94	1.96	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	7.19	2.70	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.08	5.64	1.74	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	11.66	3.29	0.60	1.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	5.06	2.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	16.50	0.66	1.32	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	9.10	2.27	1.62	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.19	2.91	2.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	12.47	2.38	0.00	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.30	1.51	1.13	1.88	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.98	1.45	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	2.51	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.03	4.12	0.16	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	1.36	4.09	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.99	1.21	0.45	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	12.86	1.07	0.00	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.26	2.65	0.76	1.13	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.29	1.87	0.53	0.80	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	7.80	2.93	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.11	2.49	1.16	0.83	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	0.00	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	16.47	3.43	0.86	0.69	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.71	3.40	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	12.90	3.04	0.76	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	14.54	0.00	1.21	3.63	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.12	1.14	1.71	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.97	3.21	0.86	0.86	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.39	2.58	1.29	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.32	1.88	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	13.18	3.22	0.96	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.99	2.14	2.85	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	5.85	2.34	1.75	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	8.73	2.11	0.90	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	1.19	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	6.61	2.54	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	11.72	3.82	0.51	1.53	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.80	1.91	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.22	3.02	1.73	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.53	3.18	2.12	0.85	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.83	2.32	1.16	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	10.39	2.83	0.00	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.39	3.90	1.19	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	6.34	0.00	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.51	3.65	1.07	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	9.02	3.01	1.80	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	11.66	0.73	0.73	1.46	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	11.72	3.91	0.92	0.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	12.97	2.29	1.02	1.02	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	15.07	4.34	1.03	0.62	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.99	3.37	0.61	0.61	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	11.95	3.82	1.91	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.53	3.33	1.33	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.97	2.77	1.66	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	13.77	1.85	1.59	0.79	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.45	4.72	1.45	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	27.14	9.33	4.18	2.46	0.37
Astrocyte - cerebellum, donor2	11580-120F5	27.73	11.47	3.94	2.57	0.51
Astrocyte - cerebellum, donor3	11661-122F5	20.76	3.36	2.10	1.68	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	17.78	4.88	3.14	1.74	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	16.34	8.74	3.40	1.78	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	15.66	9.99	2.24	0.75	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	23.17	11.35	3.67	3.67	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	21.30	14.41	3.88	4.13	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	19.00	9.56	3.76	4.21	0.46
Basophils, donor1	12241-129G9	16.22	4.97	0.78	1.05	1.83
Basophils, donor2	12242-129H1	17.68	8.30	0.72	1.44	0.00
Basophils, donor3	12243-129H2	27.93	4.85	0.00	1.47	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	12.72	0.86	0.86	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	15.09	5.03	1.37	1.37	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	16.32	5.65	2.51	2.51	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	20.17	6.65	1.46	1.25	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	10.36	3.22	0.69	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	9.00	1.98	0.54	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	27.21	15.15	3.19	3.30	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	22.82	6.29	2.56	2.33	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	25.58	11.83	1.28	2.24	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	47.90	19.72	1.13	1.69	5.07
CD14+ Monocytes, donor2	11305-117B9	56.61	17.45	0.56	2.41	1.67
CD14+ Monocytes, donor3	11381-118B4	46.32	18.88	0.44	0.44	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	24.62	8.49	0.85	0.85	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	21.23	3.79	1.52	1.90	3.03
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	23.34	5.92	0.99	1.31	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	21.10	8.96	1.16	1.30	1.45
CD14+ monocytes - mock treated, donor2	11873-125C1	13.58	7.24	0.91	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	13.03	6.63	0.24	0.47	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	15.40	7.87	1.17	1.00	2.85
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	15.18	7.18	0.28	0.83	1.93
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	15.87	10.17	0.50	1.74	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	11.75	8.81	0.20	1.37	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	10.15	4.27	0.53	0.89	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	10.45	6.31	0.87	0.65	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	13.58	9.13	0.70	2.34	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	10.03	6.86	1.06	1.06	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	18.86	15.53	1.11	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	14.43	9.82	0.89	1.04	1.19
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	13.77	6.39	0.40	0.60	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	9.16	6.87	0.42	0.83	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	12.81	9.84	1.14	0.69	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	9.50	6.56	0.45	0.23	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	12.22	5.67	0.00	0.44	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	14.26	4.57	0.00	0.54	2.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	17.10	5.58	0.70	0.70	1.74
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	13.89	7.15	0.00	1.68	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	13.23	10.84	0.18	1.29	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.40	4.23	0.70	1.76	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	12.28	4.83	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	10.64	6.97	0.00	0.52	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	9.29	7.43	0.74	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	15.74	7.76	0.65	0.43	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	13.51	7.78	0.82	1.64	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	10.20	4.87	0.46	0.46	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	10.21	7.89	0.93	1.62	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	17.44	3.49	0.44	0.44	1.53
CD14+CD16+ Monocytes, donor2	11801-124D1	23.33	3.70	0.46	0.23	2.08
CD14+CD16+ Monocytes, donor3	11912-125G4	16.46	2.60	0.22	1.08	1.95
CD14+CD16- Monocytes, donor1	11788-124B6	31.14	6.54	0.62	0.47	2.18
CD14+CD16- Monocytes, donor2	11799-124C8	20.43	4.37	0.35	0.70	2.62
CD14+CD16- Monocytes, donor3	11910-125G2	18.06	8.70	0.45	0.89	2.90
CD14-CD16+ Monocytes, donor1	11790-124B8	17.86	3.32	0.51	0.77	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	16.69	2.20	0.00	0.44	1.98
CD14-CD16+ Monocytes, donor3	11911-125G3	15.16	3.79	0.21	0.21	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	138.20	8.13	2.03	4.06	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	126.10	10.17	0.68	2.71	5.42
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	125.31	19.68	0.00	0.00	7.25
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	95.41	11.19	1.60	3.20	3.73
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	161.89	12.87	0.54	2.68	4.29
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	110.91	13.34	1.40	2.11	6.32
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	130.20	7.84	0.78	5.49	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	138.42	18.46	1.32	2.64	3.95
CD19+ B Cells, donor1	11544-120B5	118.35	16.44	1.64	1.64	6.58
CD19+ B Cells, donor2	11624-122B4	88.50	6.53	0.00	1.45	4.35
CD19+ B Cells, donor3	11705-123B4	90.87	7.57	1.51	2.02	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	194.76	21.82	8.49	4.85	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	178.17	19.58	5.19	3.60	0.80
CD34+ Progenitors, donor1	11545-120B6	14.06	4.02	0.00	4.02	0.00
CD34+ Progenitors, donor2	11625-122B5	7.87	12.36	0.56	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	39.45	6.76	0.75	2.25	2.63
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	38.56	7.44	1.35	2.03	2.48
CD4+ T Cells, donor1	11225-116C1	18.92	12.85	0.36	3.21	1.43
CD4+ T Cells, donor2	11306-117C1	23.88	15.31	0.00	3.06	0.00
CD4+ T Cells, donor3	11382-118B5	12.81	8.84	0.30	2.44	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	14.04	2.81	0.00	1.53	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	12.80	4.94	0.67	2.47	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	17.54	3.74	1.15	2.01	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	18.02	5.22	0.95	1.90	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	18.26	4.92	0.70	2.11	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	13.18	0.00	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	11.71	4.19	0.29	4.05	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	15.76	9.15	0.34	4.41	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	15.64	8.38	0.81	2.58	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	16.59	2.24	0.00	1.79	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	11.88	6.99	0.35	3.14	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	11.44	5.28	0.44	3.52	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	11.81	2.53	1.69	2.53	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	18.70	8.73	1.04	3.95	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	21.72	8.35	0.67	3.34	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	13.87	4.35	0.54	1.09	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	13.40	4.82	0.00	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	14.35	1.79	0.00	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	18.91	9.27	1.67	4.08	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	17.98	9.75	0.43	5.63	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	19.54	10.30	0.21	5.04	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	12.13	4.55	0.00	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	6.93	6.07	0.00	1.73	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	6.10	9.15	0.00	3.05	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	15.84	4.45	0.49	2.47	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	8.31	10.16	0.92	5.54	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	13.96	6.98	1.40	4.19	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	13.02	12.74	1.11	4.71	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	18.65	8.10	0.98	2.45	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	15.40	1.54	1.54	4.62	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	18.62	7.52	0.36	3.58	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	19.39	1.38	1.38	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	20.30	14.73	0.33	3.27	1.31
CD8+ T Cells, donor2	11307-117C2	22.15	11.26	0.38	2.25	1.13
CD8+ T Cells, donor3	11383-118B6	23.23	13.63	0.25	2.02	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.17	12.39	2.29	8.49	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	19.41	10.06	1.68	7.19	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	23.53	11.22	0.55	6.29	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	18.01	11.41	0.60	9.01	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	25.68	12.48	0.96	8.88	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	32.74	7.73	1.14	9.32	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	22.16	8.91	0.65	8.69	1.30
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	24.74	10.00	0.79	6.32	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.75	13.84	1.17	8.21	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	22.94	13.89	0.60	7.55	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	23.82	9.30	1.16	5.23	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	19.98	4.00	0.80	6.66	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	30.64	7.44	0.00	7.00	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.50	5.01	0.46	7.29	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.14	2.24	0.75	2.98	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	36.02	9.72	0.72	7.92	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	29.92	10.93	1.15	8.92	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	26.63	10.13	0.71	6.84	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	25.99	8.87	1.27	13.94	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	25.22	13.23	0.92	9.84	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	31.42	5.77	0.64	6.73	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	24.48	3.44	1.15	6.12	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	23.65	5.91	0.79	5.12	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.15	4.54	0.76	4.54	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	21.68	8.03	0.80	1.61	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	30.08	6.99	0.00	2.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	27.05	10.02	1.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	12.79	7.31	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	19.27	5.43	0.00	1.98	0.49
Cardiac Myocyte, donor3	11686-122I3	18.21	3.79	1.16	0.95	0.21
Chondrocyte - de diff, donor1	11261-116G1	13.52	5.55	1.39	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	14.57	0.00	1.07	1.07	0.71
Chondrocyte - de diff, donor3	11410-118E6	16.84	1.82	1.37	0.57	0.34
Chondrocyte - re diff, donor2	11339-117F7	9.85	2.69	0.00	1.79	1.79
Chondrocyte - re diff, donor3	11411-118E7	18.20	2.43	1.21	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	16.18	6.08	1.72	1.15	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	15.82	5.34	1.07	0.86	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	13.36	3.81	0.97	1.42	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	48.14	4.03	1.65	1.83	1.01
Corneal Epithelial Cells, donor1	11526-119I5	14.93	4.83	0.88	0.88	0.44
Corneal Epithelial Cells, donor2	11606-120I4	14.79	2.28	0.00	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	14.57	4.35	0.51	1.28	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	30.87	3.30	0.50	0.83	3.63
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	26.49	2.52	0.63	2.21	4.42
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	26.35	4.75	0.32	0.97	2.81
Dendritic Cells - plasmacytoid, donor1	11228-116C4	24.60	6.49	0.68	1.02	2.05
Dendritic Cells - plasmacytoid, donor2	11309-117C4	18.28	5.22	0.65	1.96	2.61
Dendritic Cells - plasmacytoid, donor3	11385-118B8	20.81	6.78	0.00	0.97	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	18.18	12.51	1.50	1.83	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	14.08	3.52	1.17	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	19.23	9.33	1.13	2.55	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	25.16	2.36	0.79	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	21.82	9.31	0.87	1.16	1.16
Endothelial Cells - Artery, donor2	11341-117F9	20.70	11.29	1.88	1.88	0.24
Endothelial Cells - Artery, donor3	11413-118E9	25.60	10.17	0.88	2.63	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	24.38	5.76	1.11	1.99	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	23.43	6.69	0.30	1.52	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	16.07	5.07	0.85	1.41	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	12.78	5.94	2.67	2.38	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	14.06	3.64	1.04	2.08	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	17.44	6.81	1.28	1.28	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	15.20	16.00	1.60	1.60	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	14.68	8.39	1.05	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	26.59	14.79	2.36	3.11	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	23.90	8.04	2.39	1.96	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	29.43	15.51	0.98	2.69	0.12
Endothelial Cells - Vein, donor1	11267-116G7	15.93	17.06	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	20.96	5.59	2.79	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	25.28	10.83	1.57	2.20	0.47
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	67.66	36.31	3.30	4.95	6.60
Eosinophils, donor3	12246-129H5	42.80	39.24	0.00	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	12.70	1.71	0.73	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	8.32	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	12.73	2.05	0.41	1.23	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	10.29	1.86	0.77	0.33	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	19.93	3.03	1.52	1.08	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	17.95	4.00	1.09	1.94	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	7.78	2.05	1.09	0.27	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	20.57	3.69	1.05	0.74	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	5.53	2.90	0.79	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	19.93	6.31	0.66	1.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	20.41	4.54	0.91	1.81	0.00
Fibroblast - Cardiac, donor2	11345-117G4	14.40	3.79	1.52	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	17.19	2.52	0.79	0.79	0.47
Fibroblast - Cardiac, donor4	11452-119A3	18.49	2.42	1.52	0.91	0.30
Fibroblast - Cardiac, donor5	11456-119A7	13.96	5.71	0.63	0.89	0.25
Fibroblast - Cardiac, donor6	11460-119B2	16.83	7.43	0.76	1.67	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	23.58	5.90	2.14	0.67	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	15.96	3.88	1.29	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	24.90	10.25	2.93	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	15.22	1.61	1.15	0.92	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	45.96	3.56	1.36	0.51	0.51
Fibroblast - Dermal, donor1	11269-116G9	16.20	2.82	1.41	0.47	0.47
Fibroblast - Dermal, donor2	11346-117G5	15.09	3.77	1.42	1.42	0.94
Fibroblast - Dermal, donor3	11418-118F5	21.52	2.42	0.73	0.48	0.24
Fibroblast - Dermal, donor4	11450-119A1	15.60	3.17	2.15	0.90	0.23
Fibroblast - Dermal, donor5	11454-119A5	13.26	6.11	1.92	1.40	0.17
Fibroblast - Dermal, donor6	11458-119A9	17.87	6.66	2.92	0.97	0.32
Fibroblast - Gingival, donor1	11237-116D4	15.83	2.71	1.25	1.67	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	13.36	2.62	0.52	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	21.48	6.72	2.24	1.45	0.13
Fibroblast - Gingival, donor3	11394-118C8	17.02	2.42	1.06	0.77	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	21.82	4.16	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	19.73	2.82	1.06	0.00	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	25.26	5.77	2.18	2.03	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	18.93	6.09	1.76	0.95	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.06	2.82	0.71	0.71	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	24.57	3.36	1.46	1.46	1.17
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	19.09	2.73	2.18	0.95	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	17.88	6.14	1.97	2.08	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	20.40	1.91	0.88	0.44	0.29
Fibroblast - Lung, donor1	11270-116H1	21.75	6.80	0.00	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	2.98	2.98	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	29.33	8.23	3.80	2.74	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	34.99	5.00	3.33	0.83	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	22.38	5.59	1.40	1.40	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	18.47	3.08	1.68	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	35.73	5.68	2.44	2.44	0.41
Fibroblast - Mammary, donor2	11620-122A9	35.95	3.99	3.99	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	41.69	0.00	5.96	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	19.59	5.63	3.49	1.55	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	22.90	7.43	2.73	1.97	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	20.50	3.37	2.45	0.61	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.13	0.38	1.14	0.76	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	14.58	2.16	1.89	1.62	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	19.02	3.36	0.93	0.35	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	12.60	5.97	2.10	1.88	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	27.84	8.13	3.25	2.24	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	23.39	4.68	2.67	2.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.58	2.77	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	9.13	9.53	0.99	1.59	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	12.97	1.24	0.53	0.00	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	10.25	2.17	0.59	0.20	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	5.42	3.01	1.20	0.90	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.87	2.70	0.86	1.08	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	5.82	3.80	0.00	0.76	0.51
Fibroblast - skin normal, donor1	11553-120C5	15.10	1.97	0.49	0.33	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	7.42	2.81	2.61	0.80	0.00
Fibroblast - skin normal, donor2	11561-120D4	12.96	5.12	1.11	1.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	7.25	5.74	0.60	0.91	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	18.14	2.07	1.16	0.66	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	16.07	3.08	0.34	0.68	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	4.27	2.63	0.33	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	10.87	4.58	1.49	1.07	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	14.17	4.55	1.18	0.51	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	5.33	1.73	0.47	0.47	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	10.46	2.61	0.00	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	16.82	4.16	1.21	1.21	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	16.66	3.38	1.82	0.78	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	19.42	3.07	1.02	0.77	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	17.61	8.42	0.77	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	12.76	10.21	1.91	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	17.97	17.12	3.71	0.86	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	14.62	3.31	3.86	0.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	12.33	6.62	2.51	0.46	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	17.24	12.09	4.16	0.79	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	13.22	7.40	2.91	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	12.72	3.59	3.59	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	15.48	11.50	5.31	1.33	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	15.55	6.08	2.97	0.42	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	15.64	5.42	2.34	0.74	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	14.24	6.72	1.88	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	14.99	5.95	1.61	1.49	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	11.77	4.57	1.11	0.97	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.82	5.29	1.63	1.42	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	15.29	7.30	1.60	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	13.20	6.35	1.37	0.87	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	16.17	5.25	1.09	0.22	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	18.91	5.91	1.48	0.30	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	13.83	5.56	1.91	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	17.20	7.37	1.34	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	18.35	9.07	1.21	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	12.89	4.75	1.19	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	20.22	7.18	2.04	0.80	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	27.68	7.49	2.39	0.83	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.13	4.61	2.05	1.02	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	17.26	4.87	1.55	0.77	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.55	6.07	1.66	1.25	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.07	6.53	1.63	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	15.47	6.19	0.62	0.83	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	18.33	3.69	2.19	0.81	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	20.51	6.34	0.83	0.67	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	18.74	2.65	1.54	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	21.89	4.55	1.60	1.60	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	19.61	6.32	0.81	1.30	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	23.73	2.57	0.96	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.90	6.06	1.52	1.04	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	18.51	6.49	0.79	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	15.81	7.60	0.91	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	17.35	6.48	1.57	1.15	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	19.32	5.05	0.66	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	16.27	4.77	1.68	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	17.50	6.76	1.11	1.11	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	15.24	4.55	0.80	1.07	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	17.44	7.34	1.07	1.07	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	15.93	6.61	2.33	1.30	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	18.70	6.78	0.54	0.54	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.96	6.82	1.47	0.74	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	23.25	6.58	1.32	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	42.65	6.94	1.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	16.49	4.09	1.06	1.45	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	18.36	4.44	0.81	1.21	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	67.10	8.90	2.03	0.51	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	14.73	5.37	2.59	1.39	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	17.56	6.47	1.69	0.62	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	19.03	11.66	2.05	1.64	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	15.33	5.63	3.76	1.56	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	16.11	7.06	1.70	1.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	14.30	5.53	1.38	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	17.32	7.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	18.57	8.90	1.55	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	24.07	3.21	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	12.17	8.69	3.48	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	14.97	7.16	2.60	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	13.59	7.82	0.82	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	16.66	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	14.82	8.11	2.52	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	13.07	3.60	1.96	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	19.29	5.03	4.19	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	17.18	6.36	1.27	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	14.95	8.15	0.68	1.02	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	12.53	8.35	6.26	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	12.60	6.87	1.72	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	11.84	6.81	0.59	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	6.78	3.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	20.30	8.28	2.49	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	14.04	8.05	1.38	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.07	6.54	1.54	1.15	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	16.62	6.19	1.96	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	18.06	4.68	3.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.49	3.08	1.16	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	26.36	12.67	2.40	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	2.48	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	20.29	2.83	1.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	22.33	6.03	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	19.33	5.60	0.00	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.94	9.17	1.60	1.60	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	18.75	4.44	0.49	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	11.80	3.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	16.92	1.75	0.58	2.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	22.38	3.95	0.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	15.26	11.02	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	16.71	4.18	0.60	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	13.10	4.85	2.43	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	3.42	3.42	3.42	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	16.63	1.66	0.83	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	30.36	12.37	2.25	3.37	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	22.52	2.22	0.00	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.04	2.92	2.51	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	17.52	6.50	2.79	1.97	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	12.66	6.75	2.87	1.52	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	16.15	4.10	2.28	1.37	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	15.19	5.36	2.40	1.64	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	18.05	4.94	3.01	1.50	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	12.70	6.67	2.58	2.37	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	14.45	4.36	2.62	0.87	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.18	5.32	2.92	1.20	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.69	2.56	1.92	1.60	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	16.79	18.47	0.56	3.92	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	16.45	8.66	2.16	2.16	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	23.79	15.86	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	29.63	2.47	2.82	2.47	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	29.06	4.36	2.18	2.91	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	19.41	6.47	1.05	2.10	0.35
Hepatocyte, donor1	11523-119I2	84.74	7.26	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	82.95	24.78	3.23	3.23	0.00
Hepatocyte, donor3	11684-122I1	63.19	5.52	2.45	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	31.33	26.76	0.65	5.22	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	44.92	11.71	3.15	0.52	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	14.54	3.57	0.82	0.82	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	3.18	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	4.15	5.54	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	10.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	23.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	5.13	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	22.74	6.50	4.87	3.25	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	10.89	3.63	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	9.26	3.97	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	8.87	9.98	2.22	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	10.48	0.00	10.48	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	13.23	5.04	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	15.47	7.73	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.21	1.94	0.65	1.94	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	17.71	4.83	3.22	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	18.74	5.70	0.00	2.44	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	13.43	2.52	1.68	0.42	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	17.68	4.02	1.61	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	6.46	2.77	2.77	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	12.27	6.61	0.94	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	5.44	7.26	3.63	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	6.46	1.08	2.15	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	10.16	6.35	2.54	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	12.75	7.65	1.91	2.55	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	14.58	3.65	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	18.57	2.14	0.71	2.14	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.66	2.16	3.40	2.47	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	12.29	3.51	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	12.57	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	15.30	0.70	2.09	2.09	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	8.85	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	12.97	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	14.82	2.62	1.74	2.62	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	19.20	6.40	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	20.78	5.54	4.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	2.85	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	13.81	5.52	3.68	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	9.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	6.34	4.23	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	16.65	1.47	0.49	1.14	0.16
Keratinocyte - epidermal, donor2	11349-117G8	8.20	1.17	0.59	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	12.68	4.83	0.66	0.85	0.28
Keratinocyte - oral, donor1	11251-116E9	25.43	1.59	1.48	1.14	0.34
Keratocytes, donor1	11527-119I6	17.88	3.09	0.69	1.03	0.00
Keratocytes, donor2	11607-120I5	11.72	3.52	0.00	2.34	0.00
Keratocytes, donor3	11688-122I5	15.41	1.78	0.40	0.59	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	8.79	8.79	6.59	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	9.71	5.39	1.08	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	20.76	5.31	2.88	0.92	0.00
Lens Epithelial Cells, donor3	11690-122I7	10.09	2.62	0.61	1.01	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	24.43	9.49	1.42	2.13	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.63	11.44	1.95	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	16.69	10.07	0.94	2.52	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	11.29	5.38	0.54	2.15	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	20.80	10.09	1.26	3.47	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	14.66	9.81	1.08	2.37	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.18	7.39	0.82	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.18	12.89	2.02	3.79	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	14.36	10.27	1.55	2.67	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	13.05	10.28	1.98	3.96	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.41	13.96	1.16	3.10	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	16.66	13.15	1.11	2.59	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	15.33	8.71	1.74	4.18	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	17.89	14.07	1.91	1.91	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	17.72	10.03	1.51	3.30	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	13.55	14.47	1.23	1.85	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	13.09	11.85	1.56	1.56	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	18.48	11.71	1.83	2.56	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	14.15	10.53	0.66	3.62	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	17.28	12.01	2.93	2.64	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	15.43	13.94	1.49	2.49	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	15.03	12.61	1.45	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.46	16.16	1.08	0.81	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.74	9.54	1.97	2.42	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.37	7.78	0.00	2.07	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.33	13.40	1.88	2.09	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	18.04	12.63	2.26	3.61	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	12.38	7.57	2.06	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	12.98	10.91	1.51	2.26	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	18.56	11.77	1.38	3.18	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	13.57	12.11	0.48	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.57	9.92	1.98	2.32	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	20.81	12.64	1.61	2.85	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.44	9.63	1.48	1.85	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	13.34	12.35	1.24	0.99	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.91	9.90	0.96	2.75	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	16.73	10.94	1.61	3.22	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	13.39	11.56	1.83	1.52	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	16.10	10.08	0.84	2.52	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.80	8.89	1.07	3.20	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.21	13.57	4.85	3.39	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	14.94	13.07	2.65	2.18	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	17.55	10.74	1.79	3.22	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	12.09	13.39	2.29	1.96	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.59	11.54	3.06	1.88	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	21.16	12.62	2.60	2.72	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	16.65	14.86	1.02	1.28	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.62	11.93	0.60	1.49	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	6.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.97	4.60	1.53	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	14.84	6.68	1.48	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	13.54	2.96	2.12	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.25	4.92	1.41	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	11.21	2.80	1.87	3.74	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	14.94	7.21	2.06	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	5.95	2.38	0.00	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.51	5.43	1.58	1.36	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.70	2.91	2.04	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	12.60	2.25	1.35	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	20.05	6.77	2.17	1.63	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	7.19	5.65	0.00	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	15.88	5.29	1.41	1.76	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.99	3.33	0.00	1.33	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.77	8.15	0.51	2.04	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.81	6.94	1.87	2.13	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	14.74	7.18	0.94	1.13	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.95	7.36	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	16.31	3.26	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11.45	6.25	1.25	1.25	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	12.61	5.04	1.12	1.40	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	8.24	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	12.48	5.81	1.74	1.16	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.76	2.99	1.79	1.79	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.85	3.32	1.11	4.43	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	16.26	6.72	1.06	2.12	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.64	4.79	0.74	1.11	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	2.30	0.00	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.19	9.21	0.77	2.69	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	10.19	7.93	2.26	2.83	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	16.41	4.10	0.00	0.82	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.10	9.04	1.81	1.81	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	16.52	7.18	1.44	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	3.73	0.75	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	14.49	8.18	2.60	1.86	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	8.61	4.31	0.43	1.72	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	6.85	4.28	0.00	2.57	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	14.66	7.33	1.00	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.26	4.83	1.21	0.60	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.24	5.69	0.00	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	14.78	5.16	1.37	1.37	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	9.66	7.51	1.07	1.61	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.81	9.43	2.69	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	18.52	8.89	1.11	1.11	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	9.30	3.49	1.16	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	14.81	5.29	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	17.61	10.80	3.60	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	12.36	5.09	1.45	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.80	6.90	0.00	2.30	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	20.72	5.43	0.49	2.47	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	10.35	3.76	0.94	0.94	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	22.12	10.56	1.01	1.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	12.17	9.01	2.70	0.45	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	3.44	1.72	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	13.81	7.13	1.34	1.34	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	14.08	7.04	0.78	1.56	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.19	7.26	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	20.24	5.71	0.52	3.11	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	10.94	4.38	3.06	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	10.62	3.35	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.11	8.83	0.88	2.65	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.90	6.17	1.16	1.93	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	10.63	8.61	0.00	2.53	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.98	4.81	0.96	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.13	7.16	0.80	1.19	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	11.54	4.25	2.43	1.22	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.22	6.23	2.08	4.15	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	18.62	4.56	0.76	0.76	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	11.88	2.07	0.52	0.52	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.30	9.07	2.42	0.00	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	13.94	8.24	1.27	0.95	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	14.39	4.80	1.07	3.20	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.07	7.47	1.72	1.72	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	16.97	6.69	2.57	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	18.39	4.95	0.71	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	10.78	10.21	1.70	2.84	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	15.81	7.07	0.83	2.08	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	10.96	7.83	2.35	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	14.20	5.85	0.84	1.25	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	19.98	8.36	0.93	2.32	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.73	4.68	2.01	2.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	13.37	7.48	2.14	3.21	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	12.12	7.27	0.81	1.21	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	14.68	4.59	0.00	2.75	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.00	3.56	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	17.67	6.27	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12.27	4.60	0.77	0.77	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	14.77	4.92	1.64	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.48	3.56	1.78	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	23.66	4.16	0.78	2.60	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	16.58	7.29	0.00	0.00	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	6.24	2.08	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	16.87	5.70	0.46	0.23	0.68
Macrophage - monocyte derived, donor2	11313-117C8	17.98	3.85	0.37	0.37	1.65
Macrophage - monocyte derived, donor3	11389-118C3	22.55	7.86	0.66	0.92	1.70
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	10.62	3.19	0.00	1.59	0.00
Mallassez-derived cells, donor2	11929-125I3	17.91	2.54	1.90	1.27	0.48
Mallassez-derived cells, donor3	11930-125I4	10.84	3.75	1.25	1.11	0.83
Mammary Epithelial Cell, donor1	11273-116H4	12.95	2.79	1.10	0.80	0.20
Mammary Epithelial Cell, donor2	11350-117G9	12.16	2.90	1.45	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	20.20	9.98	3.24	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	12.88	4.75	0.00	2.71	0.68
Mast cell, donor1	11563-120D6	43.91	9.95	0.87	3.24	2.49
Mast cell, donor2	11565-120D8	39.52	9.21	0.30	2.08	2.38
Mast cell, donor3	11566-120D9	46.15	7.20	0.45	0.90	2.03
Mast cell, donor4	11567-120E1	52.65	8.69	0.53	0.89	1.95
Mast cell, expanded and stimulated, donor5	11940-126A5	26.39	4.32	0.11	2.11	2.00
Mast cell, expanded and stimulated, donor8	11942-126A7	14.01	6.42	0.58	4.67	1.75
Mast cell, expanded, donor5	11939-126A4	48.07	9.06	1.15	2.18	2.29
Mast cell, expanded, donor8	11941-126A6	33.81	13.56	1.17	4.35	2.18
Melanocyte - dark, donor1	11502-119F8	20.70	14.13	1.89	2.39	0.70
Melanocyte - dark, donor2	11582-120F7	13.50	6.92	0.69	2.42	0.35
Melanocyte - dark, donor3	11663-122F7	35.71	8.11	1.88	3.48	1.16
Melanocyte - light, donor1	11274-116H5	21.86	4.00	1.41	1.41	1.18
Melanocyte - light, donor2	11351-117H1	31.39	7.51	0.68	2.73	1.36
Melanocyte - light, donor3	11423-118G1	21.68	6.07	0.87	0.87	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	19.99	5.41	1.87	2.71	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	18.02	1.61	1.61	1.34	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	29.46	3.75	1.07	0.27	1.07
Meningeal Cells, donor1	11493-119E8	26.30	11.91	3.72	2.73	0.62
Meningeal Cells, donor2	11573-120E7	21.13	7.92	1.76	0.44	0.00
Meningeal Cells, donor3	11654-122E7	21.11	9.62	3.34	1.96	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	22.53	2.85	2.28	0.86	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.07	1.51	0.81	0.30	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	21.03	2.63	2.63	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	26.16	3.92	2.62	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	17.22	7.18	1.44	5.02	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	10.38	1.91	1.69	0.64	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	10.05	3.02	0.50	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	24.39	6.59	3.96	3.96	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	33.61	11.69	1.46	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	26.19	10.84	3.48	2.05	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.44	3.05	1.39	0.42	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	27.14	3.72	0.74	0.74	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	27.10	3.42	1.18	0.92	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	24.33	3.26	1.48	1.48	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	24.34	2.56	1.92	2.56	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	17.37	7.44	0.71	1.77	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	20.64	3.75	0.63	0.63	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	17.42	9.43	0.00	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	20.42	3.18	1.86	1.06	0.00
Mesothelial Cells, donor2	12156-128G5	10.51	1.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	15.18	2.67	0.65	0.65	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	31.06	2.70	0.00	0.00	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	20.44	9.11	0.00	1.97	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	26.50	5.89	0.00	2.65	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	19.53	5.89	0.31	0.62	1.55
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	19.50	4.77	0.62	0.83	2.07
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	9.26	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	21.77	5.01	0.75	1.50	2.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	18.15	6.05	0.00	1.40	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	18.29	5.69	0.61	1.42	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	25.74	6.34	0.00	1.98	2.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	3.54	0.00	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	26.22	3.42	0.38	1.90	2.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	26.32	6.58	1.32	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	16.13	5.52	0.42	0.85	1.49
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	12.89	2.76	0.00	0.00	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	17.88	6.26	0.30	1.19	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	30.18	3.35	3.35	0.00	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.30	7.53	0.25	1.00	1.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.59	3.09	0.00	1.90	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	21.56	4.98	0.55	0.55	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	14.74	8.29	0.23	2.07	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	22.51	4.00	0.63	1.05	1.26
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	24.87	5.91	0.61	1.22	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	14.59	7.94	0.43	1.93	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.01	6.89	0.67	1.78	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	30.96	0.00	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	16.43	2.63	0.22	1.31	1.75
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.69	3.04	0.51	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	34.80	8.28	1.66	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	15.76	5.16	0.27	0.82	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	25.59	4.71	0.59	1.47	3.23
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	25.08	8.72	1.09	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	13.46	7.69	0.96	1.92	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	25.21	7.20	0.80	1.20	2.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	27.42	5.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	26.03	7.01	0.50	1.00	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	4.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	18.39	10.07	0.88	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	26.49	12.14	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	22.41	16.65	1.28	1.92	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	18.59	13.64	1.98	2.73	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	21.57	5.57	0.00	1.39	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	37.57	11.05	2.21	4.42	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	16.07	11.28	1.03	2.74	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	25.38	10.94	0.44	3.06	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	20.60	11.01	1.78	0.36	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	20.76	14.31	1.96	4.49	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	23.28	9.14	0.42	2.08	3.33
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	19.23	10.49	2.33	1.17	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	16.89	14.18	2.11	2.41	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	27.97	6.68	0.00	2.50	3.34
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	14.44	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	11.08	1.85	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	25.04	9.68	1.14	3.41	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.51	8.57	0.97	2.21	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	18.14	8.03	2.07	2.59	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	27.03	7.29	0.86	1.29	3.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.06	11.43	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	15.75	7.47	0.53	1.60	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	19.16	11.67	1.20	1.20	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	10.88	7.77	1.27	1.55	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.78	9.24	1.59	3.82	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	21.89	8.62	0.22	2.87	2.21
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	16.31	13.65	1.14	1.90	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	12.22	8.52	1.42	1.99	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	19.17	10.08	1.97	2.46	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.73	8.47	0.65	1.96	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.88	9.41	1.47	0.88	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	19.03	6.34	1.15	1.73	2.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.84	3.30	0.41	1.24	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	15.19	6.55	2.08	3.57	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	3.77	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	3.56	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	19.06	6.57	0.66	0.66	2.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	7.36	4.21	2.10	1.05	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	14.43	3.95	1.19	0.99	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	22.35	2.79	0.00	0.00	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	14.27	8.26	0.75	1.50	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.91	7.46	0.80	0.80	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	10.18	3.17	0.57	1.47	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	18.42	2.95	0.00	1.47	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	16.12	5.86	0.00	0.37	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	3.11	1.56	3.11	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.53	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	11.59	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	16.16	8.08	0.00	1.01	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	3.37	1.26	1.26	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	62.81	11.42	0.00	5.71	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	13.05	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	0.00	0.00	4.75	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	138.04	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	12.71	3.88	0.00	1.08	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	13.07	1.57	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	13.35	4.00	2.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	13.36	1.25	1.25	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	5.70	3.04	1.52	0.95	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	1.60	6.38	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	15.64	3.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	0.00	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	15.90	2.51	1.26	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	14.41	5.35	1.39	1.39	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.86	2.43	0.54	1.08	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.03	2.73	1.47	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	11.91	2.48	1.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	8.39	1.89	1.62	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.51	3.17	1.81	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	17.80	2.78	1.14	0.65	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	14.22	4.37	1.09	0.55	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	15.91	2.65	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.60	1.80	2.40	1.20	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	1.64	1.97	1.31	0.98	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	15.12	2.76	1.63	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	17.81	1.76	1.23	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	1.41	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	11.95	1.38	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.07	1.61	0.64	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	6.55	2.41	1.03	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	10.92	4.01	1.11	0.45	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	11.43	2.96	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.02	2.61	1.19	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	17.60	1.72	1.72	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	17.33	1.00	0.67	0.67	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	12.62	1.80	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	16.67	1.98	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	0.93	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.51	2.27	0.76	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.69	1.96	0.98	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	8.72	0.44	0.44	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	16.28	1.36	0.90	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	1.76	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	16.62	0.00	1.99	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	16.87	1.98	0.50	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.02	1.53	0.00	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	8.47	2.72	0.60	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	10.39	1.77	0.66	1.11	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.84	2.71	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	17.07	1.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.96	0.63	0.94	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.29	1.21	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	2.37	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	4.53	1.13	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	11.80	3.11	1.37	0.50	0.00
Myoblast, donor2	11322-117D8	14.58	3.07	2.30	1.34	0.38
Myoblast, donor3	11398-118D3	16.48	1.85	1.18	0.84	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	25.54	7.30	0.88	1.17	0.29
Natural Killer Cells, donor1	11230-116C6	14.45	11.07	0.92	2.77	0.62
Natural Killer Cells, donor2	11311-117C6	15.08	13.27	0.90	3.02	1.21
Natural Killer Cells, donor3	11387-118C1	21.17	18.22	0.74	2.21	1.29
Neural stem cells, donor1	11275-116H6	13.43	2.90	0.73	0.36	0.00
Neural stem cells, donor2	11352-117H2	15.41	5.78	1.93	0.00	0.00
Neurons, donor1	11494-119E9	5.69	2.28	2.28	5.69	0.00
Neurons, donor2	11574-120E8	15.85	3.96	3.08	2.86	0.22
Neurons, donor3	11655-122E8	7.40	4.93	1.64	3.29	0.00
Neutrophils, donor1	11233-116C9	36.19	28.77	0.00	0.00	0.93
Neutrophils, donor2	11314-117C9	40.58	14.49	0.00	0.00	5.80
Neutrophils, donor3	11390-118C4	50.09	25.04	0.61	1.83	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	29.92	3.68	2.14	1.07	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	19.54	3.26	1.95	0.98	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	16.65	3.01	0.80	0.80	0.20
Olfactory epithelial cells, donor1	11933-125I7	15.97	3.17	0.69	0.55	0.96
Olfactory epithelial cells, donor2	11934-125I8	12.74	3.18	1.74	0.72	0.43
Olfactory epithelial cells, donor3	11935-125I9	13.39	2.84	0.91	0.45	0.34
Olfactory epithelial cells, donor4	11936-126A1	19.97	3.31	1.27	0.00	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	15.65	7.22	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	18.29	2.77	0.43	0.64	1.06
Osteoblast - differentiated, donor2	11353-117H3	12.57	2.29	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	11.17	1.86	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	20.72	5.28	3.13	0.98	0.98
Osteoblast, donor2	11354-117H4	14.75	5.62	0.70	2.11	0.00
Osteoblast, donor3	11426-118G4	25.77	4.80	1.42	2.13	0.18
Pancreatic stromal cells, donor1	11249-116E7	20.97	5.31	2.11	1.10	0.42
Pericytes, donor1	11491-119E6	25.59	3.67	1.67	1.00	0.56
Pericytes, donor2	11571-120E5	24.22	6.34	3.17	1.13	0.45
Pericytes, donor3	11652-122E5	25.02	5.29	0.61	1.02	0.00
Perineurial Cells, donor1	11499-119F5	21.47	4.52	1.81	1.81	0.11
Perineurial Cells, donor2	11579-120F4	22.63	6.53	0.83	1.29	0.74
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	27.09	6.06	0.32	2.87	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	26.45	9.06	0.49	1.96	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	22.39	9.97	0.26	2.46	0.78
Placental Epithelial Cells, donor1	11278-116H9	16.02	7.41	4.07	1.20	0.48
Placental Epithelial Cells, donor2	11355-117H5	22.18	2.22	3.33	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	20.81	6.48	2.75	0.39	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.86	1.27	0.63	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	15.01	0.75	0.56	0.19	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	5.35	1.57	0.52	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	16.44	1.58	1.13	0.68	0.45
Preadipocyte - omental, donor1	11468-119C1	14.17	2.24	1.07	1.07	0.00
Preadipocyte - omental, donor2	11329-117E6	14.84	3.93	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	14.04	1.86	0.29	0.86	0.57
Preadipocyte - perirenal, donor1	11469-119C2	16.73	2.95	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	23.03	2.76	1.54	3.38	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	33.82	7.26	1.24	1.06	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	20.60	5.96	1.70	1.19	0.68
Preadipocyte - visceral, donor1	11280-116I2	22.82	6.05	2.24	1.49	0.47
Preadipocyte - visceral, donor2	11357-117H7	23.93	2.76	4.14	2.30	0.46
Preadipocyte - visceral, donor3	11429-118G7	18.91	4.60	2.19	0.52	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	30.77	11.77	1.96	1.81	0.91
Prostate Epithelial Cells, donor2	11331-117E8	14.35	3.79	0.54	0.68	0.14
Prostate Epithelial Cells, donor3	11404-118D9	8.76	1.78	0.61	0.31	0.00
Prostate Stromal Cells, donor1	11254-116F3	17.54	6.04	2.39	1.82	0.34
Prostate Stromal Cells, donor2	11332-117E9	22.23	6.28	2.33	2.15	0.54
Prostate Stromal Cells, donor3	11405-118E1	26.80	3.86	2.29	0.73	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.15	6.57	4.01	1.46	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	14.76	5.34	2.22	0.49	0.07
Renal Epithelial Cells, donor1	11517-119H5	31.45	12.68	7.10	4.06	0.51
Renal Epithelial Cells, donor2	11597-120H4	20.63	6.40	3.56	4.98	0.00
Renal Epithelial Cells, donor3	11678-122H4	15.99	5.93	2.33	0.64	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	26.55	18.38	2.72	2.04	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	20.48	13.48	2.16	1.48	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	16.21	12.65	0.89	3.55	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	27.28	8.65	2.00	2.66	0.67
Renal Mesangial Cells, donor1	11518-119H6	21.35	5.50	3.08	1.98	0.22
Renal Mesangial Cells, donor2	11598-120H5	36.37	7.52	5.64	2.51	0.00
Renal Mesangial Cells, donor3	11679-122H5	22.75	6.94	3.33	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	18.25	16.11	3.76	2.15	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.39	8.86	2.95	1.27	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	23.72	10.41	4.24	1.93	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	21.00	5.44	2.59	2.07	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	13.64	7.96	3.70	1.14	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	16.47	3.09	6.17	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.78	2.01	1.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	56.93	7.48	2.00	1.07	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	13.40	5.36	0.00	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	2.75	6.05	1.65	2.75	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	5.22	8.70	1.16	2.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	8.19	11.44	2.21	2.21	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	10.43	11.02	2.78	2.28	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	10.15	11.38	4.57	1.56	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	10.67	16.25	3.47	1.74	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	10.26	13.29	3.38	2.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	10.40	11.79	2.31	2.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	7.53	11.77	3.01	1.64	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	8.77	12.10	3.63	2.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	9.86	9.32	2.33	1.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.61	15.49	2.01	2.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	9.98	12.66	3.65	2.15	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	10.62	15.49	2.88	1.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	6.50	12.81	2.10	1.53	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	9.41	11.83	3.73	1.77	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	9.40	10.33	3.95	1.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	6.64	16.19	2.26	1.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	10.80	13.24	1.75	3.21	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	9.17	12.60	2.67	1.72	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	8.44	14.63	1.92	1.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	10.37	10.65	3.92	3.08	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	8.37	14.36	3.25	2.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	7.66	10.21	3.10	2.19	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	11.40	15.57	4.66	1.59	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	11.28	14.51	3.49	1.88	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	5.19	16.51	2.83	2.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	12.70	14.48	2.38	1.98	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	10.06	17.30	3.27	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	7.26	11.61	4.98	2.07	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	7.96	9.51	3.76	2.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	8.98	12.32	5.43	1.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	6.46	19.11	6.06	2.83	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	8.69	11.58	3.41	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	11.76	13.88	4.43	2.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	6.71	14.61	3.78	2.75	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	8.64	10.97	3.15	2.19	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	8.04	13.13	4.10	2.79	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	5.62	12.95	2.90	2.39	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	15.39	15.98	3.85	2.66	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	10.93	11.73	1.87	0.80	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	9.54	12.58	2.49	0.83	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	15.00	9.76	3.57	3.10	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	13.50	14.11	1.61	1.41	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.66	13.18	2.54	1.98	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	10.48	10.13	2.10	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	9.97	10.88	1.81	3.32	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	10.04	15.30	2.45	2.33	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	11.94	13.10	3.06	1.60	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	16.43	10.34	1.83	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	10.25	10.25	2.41	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	11.31	12.44	2.04	1.36	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	13.48	16.47	1.80	2.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	7.32	12.99	0.94	1.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	8.96	13.02	1.49	1.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	11.42	13.22	1.20	0.60	0.00
Schwann Cells, donor1	11498-119F4	23.32	9.59	3.39	1.69	0.00
Schwann Cells, donor2	11578-120F3	34.02	13.61	0.00	3.40	3.40
Schwann Cells, donor3	11659-122F3	23.88	4.16	2.41	2.41	0.66
Sebocyte, donor1	11220-116B5	24.10	3.83	2.74	2.19	0.55
Sebocyte, donor2	11301-117B5	15.62	1.38	1.84	1.38	0.46
Sebocyte, donor3	11378-118B1	21.02	2.27	1.24	0.41	0.00
Sertoli Cells, donor1	11255-116F4	23.19	4.97	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	16.95	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	19.09	3.78	1.06	0.62	0.18
Skeletal Muscle Cells, donor2	11358-117H8	14.46	2.89	0.72	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	20.06	10.03	3.34	4.18	0.84
Skeletal Muscle Cells, donor4	11451-119A2	16.34	7.07	1.41	1.26	0.16
Skeletal Muscle Cells, donor5	11455-119A6	19.62	6.54	0.89	1.64	0.15
Skeletal Muscle Cells, donor6	11459-119B1	20.32	6.46	2.62	2.46	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	19.78	2.65	2.02	1.89	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	22.40	3.14	1.43	0.57	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	22.92	7.04	2.38	1.39	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	32.52	5.64	1.52	1.10	0.93
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.03	5.79	2.17	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	18.58	4.13	2.06	1.38	0.83
Skin - palm, donor1	10286-104F7	16.12	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.06	3.03	1.44	1.01	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	4.09	4.09	0.82	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.61	3.89	1.04	1.17	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	11.82	2.50	0.83	0.28	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	10.13	2.39	0.84	0.84	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	11.84	5.29	0.63	1.69	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	12.52	3.75	0.52	0.52	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.96	3.39	1.23	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	3.78	2.89	0.89	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	19.40	8.23	1.18	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	21.44	3.54	1.10	0.66	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.87	4.73	2.76	3.15	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	24.72	6.18	2.32	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	21.02	2.00	0.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	14.64	3.06	0.80	0.40	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	19.06	3.32	0.89	2.22	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	15.36	4.23	1.02	0.64	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	19.54	3.91	0.98	1.95	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	23.04	4.13	1.48	1.18	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	17.37	5.41	1.00	1.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	27.00	6.02	2.60	1.95	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.61	3.65	0.00	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	25.76	3.79	1.77	0.51	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.49	4.77	0.48	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	13.13	5.01	1.92	0.44	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	15.50	4.09	1.51	0.86	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	16.27	5.25	2.41	1.05	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	26.76	6.65	2.32	0.77	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	30.18	4.31	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	14.64	6.57	2.69	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	24.24	5.46	3.41	3.41	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	25.52	2.59	1.65	0.94	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	15.60	1.61	0.40	1.01	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	27.53	4.78	0.68	0.68	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.30	7.85	1.81	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	25.43	9.54	4.24	2.38	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	14.11	2.93	1.60	1.33	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	21.41	3.38	1.50	0.13	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	23.84	3.55	1.01	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	18.85	4.52	2.11	1.81	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.01	4.50	2.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	10.34	6.46	1.29	5.17	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	24.18	5.12	2.33	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	18.68	2.52	0.50	1.51	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	11.91	2.19	0.00	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	21.83	3.54	0.29	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	30.99	6.50	2.17	1.92	0.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	23.36	2.80	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	17.99	5.18	1.30	1.01	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	17.34	5.61	2.29	0.25	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	17.68	5.64	1.13	1.13	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	14.39	5.17	3.49	2.10	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	16.67	2.51	0.50	0.75	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	12.38	2.86	1.90	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	15.41	4.16	1.22	0.98	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.48	2.21	0.66	0.88	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	12.87	2.63	0.88	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	9.72	2.53	0.78	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.93	4.76	0.26	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	3.35	0.74	0.74	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.26	2.87	1.08	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	10.79	1.99	0.57	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.24	4.33	1.18	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	6.60	1.52	0.25	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	13.18	1.60	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	10.87	1.67	0.00	0.00	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	8.71	3.21	0.46	0.92	0.00
Synoviocyte, donor1	11291-117A4	15.99	2.69	1.01	1.01	0.50
Synoviocyte, donor2	11368-117I9	19.95	2.35	0.67	1.01	0.17
Synoviocyte, donor3	11440-118H9	12.96	1.34	0.67	0.89	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	26.80	10.36	6.07	1.43	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	25.47	5.09	1.16	1.16	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	11.40	2.37	1.51	0.43	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	10.82	5.03	0.77	1.93	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	12.03	1.72	1.15	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	58.81	6.64	1.48	1.35	0.98
Urethra, donor2	10319-105A4	14.39	3.60	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	14.35	3.72	0.27	0.27	0.27
Urothelial Cells, donor2	11600-120H7	10.01	1.60	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	12.61	5.04	0.69	1.15	0.23
Urothelial cells, donor0	11216-116B1	20.51	5.57	1.34	0.67	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	250.03	16.91	0.00	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	363.12	7.15	0.00	1.43	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	206.04	5.48	1.37	0.00	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	80.23	9.64	0.69	2.07	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	99.36	12.20	3.49	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	207.21	8.33	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	246.89	8.26	0.00	0.92	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	258.35	10.04	0.91	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	14.68	9.13	2.84	1.73	0.74
Wilms' tumor cell line:HFWT	10597-108E3	5.28	4.40	1.76	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	13.97	5.59	1.96	1.96	0.00
achilles tendon, donor2	10292-104G4	6.20	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	24.48	5.86	1.53	2.80	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	29.25	10.91	3.25	4.88	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	24.45	11.28	2.85	2.37	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	19.32	15.78	3.27	4.63	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	25.30	12.09	2.25	1.69	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	23.05	10.79	1.69	2.54	1.69
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	20.14	4.08	1.09	2.45	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	23.79	3.08	0.88	0.88	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	33.49	8.98	1.23	3.27	4.08
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	51.64	16.31	1.94	3.88	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	27.23	4.05	1.66	1.29	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	19.50	3.90	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	24.63	11.39	1.63	4.42	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	15.79	19.68	4.92	3.62	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	20.46	12.27	4.38	1.75	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	11.62	6.04	1.86	1.39	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	23.44	9.87	0.82	4.11	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	30.70	11.66	1.53	3.68	1.53
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	33.28	16.21	7.68	4.27	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	37.00	14.56	4.55	3.34	2.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	36.11	19.50	5.30	3.37	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	28.51	7.57	1.56	2.23	1.78
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	10.34	5.00	1.33	2.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	27.87	11.15	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	29.38	10.17	3.39	1.51	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	23.12	6.54	1.31	3.05	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	31.87	3.75	1.87	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	29.20	7.30	1.65	0.47	0.71
adipose tissue, adult, pool1	10010-101C1	34.75	4.50	0.93	1.09	0.78
adipose, donor1	10184-103D4	2.35	2.93	1.76	1.17	1.17
adipose, donor2	10185-103D5	6.49	1.62	0.81	0.41	0.00
adipose, donor3	10186-103D6	6.53	4.36	0.82	0.54	0.00
adipose, donor4	10187-103D7	6.07	5.20	1.73	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	7.89	6.63	3.95	1.89	0.16
adrenal gland, adult, pool1	10081-102A9	21.83	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	12.27	1.60	0.27	2.40	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	10.00	6.43	3.22	1.07	0.00
amniotic membrane cells, donor1	12235-129G3	9.51	2.55	1.62	0.70	0.46
amniotic membrane cells, donor2	12236-129G4	7.44	4.06	0.68	1.35	0.00
amniotic membrane cells, donor3	12237-129G5	8.25	3.54	0.00	0.59	0.00
amygdala - adult, donor10196	10167-103B5	15.42	0.00	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	18.86	2.03	0.41	1.22	0.00
amygdala, newborn, donor10223	10360-105E9	6.13	2.26	1.94	0.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	18.72	4.33	1.78	1.27	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	28.46	12.35	3.53	3.97	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	17.70	11.36	2.67	1.67	1.34
aorta, adult, pool1	10052-101G7	14.51	3.33	0.39	0.78	0.00
appendix, adult	10189-103D9	36.48	6.60	1.55	2.33	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	50.56	5.85	2.41	1.38	0.69
artery, adult	10190-103E1	51.63	2.72	0.00	1.36	2.72
astrocytoma cell line:TM-31	10425-106D2	18.69	7.24	1.59	2.61	0.43
b cell line:RPMI1788	10427-106D4	35.69	6.39	1.19	2.83	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	23.03	1.39	1.66	1.11	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	12.90	4.86	2.48	1.49	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	6.36	9.37	2.18	1.17	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	20.13	8.39	1.12	1.68	1.12
bladder, adult, pool1	10011-101C2	30.09	3.80	1.52	0.54	0.43
blood, adult, pool1	10053-101G8	159.45	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.99	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	24.29	4.72	1.35	2.02	0.00
brain, adult, donor1	10084-102B3	18.45	1.03	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	14.37	0.89	0.33	0.56	0.22
brain, fetal, pool1	10085-102B4	16.03	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	14.87	4.96	1.65	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	47.56	9.24	2.50	1.00	0.75
breast, adult, donor1	10080-102A8	33.46	2.53	0.00	1.26	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	10.93	1.27	0.38	0.76	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	14.22	5.57	3.71	1.24	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	7.37	8.06	6.91	1.84	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	38.49	10.17	7.50	3.15	1.45
carcinoid cell line:NCI-H1770	10703-109H1	11.28	6.58	2.82	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	15.64	3.72	0.88	1.31	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	18.38	5.07	2.54	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	20.50	10.65	4.53	2.13	0.00
caudate nucleus - adult, donor10196	10177-103C6	6.91	0.00	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	15.23	2.18	0.67	1.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	9.17	1.53	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	5.86	2.56	0.37	0.73	0.37
cerebellum - adult, donor10196	10173-103C2	26.22	2.91	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	16.87	3.20	0.43	1.28	0.00
cerebellum, adult, pool1	10083-102B2	8.62	0.34	0.00	1.72	0.00
cerebellum, newborn, donor10223	10357-105E6	9.13	3.32	0.83	0.83	0.00
cerebral meninges, adult	10188-103D8	13.11	1.26	0.25	1.01	0.25
cerebrospinal fluid, donor2	10294-104G6	24.85	0.73	0.00	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	18.12	3.31	2.01	1.15	0.29
cervical cancer cell line:ME-180	10553-107I4	15.25	3.48	1.33	1.16	0.33
cervix, adult, pool1	10013-101C4	25.20	3.25	0.52	1.15	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	10.03	5.02	1.11	1.11	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	13.06	2.61	2.61	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	10.94	3.48	1.12	1.37	0.37
choriocarcinoma cell line:SCH	10785-110H2	7.15	3.70	1.36	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	9.25	2.85	0.95	0.47	0.24
chorionic membrane cells, donor1	12238-129G6	19.94	2.56	1.14	1.42	0.85
chorionic membrane cells, donor2	12239-129G7	18.69	4.08	0.70	0.99	0.20
chorionic membrane cells, donor3	12240-129G8	14.84	3.30	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	13.13	6.06	1.01	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	20.36	5.38	0.38	1.92	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	48.15	5.07	1.06	1.06	2.53
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	10.53	3.34	1.54	1.03	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	14.51	5.08	0.97	0.97	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	8.96	4.89	1.83	2.04	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	10.01	4.42	3.24	1.18	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	38.31	7.30	2.09	1.30	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	14.40	5.94	2.97	2.74	0.00
clear cell carcinoma cell line:TEN	10636-108I6	11.80	2.78	2.43	0.35	0.35
colon carcinoma cell line:CACO-2	10513-107D9	22.33	11.53	4.03	1.10	0.73
colon carcinoma cell line:COLO-320	10420-106C6	30.03	6.08	4.94	1.90	0.00
colon, adult, donor1	10082-102B1	38.08	4.76	3.57	0.00	0.00
colon, adult, pool1	10014-101C5	103.87	7.29	1.65	1.06	1.88
colon, fetal, donor1	10070-101I7	53.15	6.18	0.62	0.62	2.47
common myeloid progenitor CMP, donor1	12130-128D6	119.17	32.08	0.00	0.00	9.17
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	25.92	10.20	2.12	2.12	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	25.36	9.81	0.91	5.89	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	27.92	11.00	0.42	7.61	0.71
corpus callosum, adult, pool1	10042-101F6	27.42	2.76	0.55	2.10	0.77
cruciate ligament, donor2	10295-104G7	8.92	4.05	0.81	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	34.51	4.01	1.61	1.61	0.80
diencephalon, adult	10193-103E4	10.08	1.92	0.48	0.72	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	40.87	9.87	1.84	3.21	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.33	4.36	1.80	2.05	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	11.55	2.65	0.96	0.24	0.00
ductus deferens, adult	10196-103E7	21.43	2.99	1.00	2.49	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	56.17	2.88	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	36.78	3.68	0.74	0.74	0.00
dura mater, adult, donor1	10041-101F5	28.58	4.71	0.74	1.82	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	25.09	8.66	2.22	0.67	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	16.91	11.61	5.02	1.29	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	7.40	6.78	4.32	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	7.87	4.84	2.72	1.21	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	7.41	7.10	2.47	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	9.19	7.88	2.63	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	19.44	4.36	0.67	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	10.87	4.17	2.90	1.45	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	7.40	3.22	2.09	0.80	0.16
epidermoid carcinoma cell line:A431	10426-106D3	21.90	3.56	0.22	1.33	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	26.07	18.70	5.28	1.98	0.22
epididymis, adult	10197-103E8	24.28	2.51	0.63	1.05	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	6.92	2.31	1.24	1.42	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.93	4.72	1.18	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	15.33	6.81	3.28	1.70	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	15.26	8.86	3.54	0.59	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	19.72	6.50	2.80	1.90	0.45
esophagus, adult, pool1	10015-101C6	28.14	4.25	1.91	0.21	1.17
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	10.14	5.26	2.00	1.38	0.00
eye - muscle inferior rectus, donor1	10272-104E2	31.39	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	23.15	2.10	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	34.23	1.49	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	26.37	4.59	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	8.74	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	16.27	1.53	0.25	0.76	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	12.95	6.41	1.28	1.92	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	7.12	5.94	1.66	1.90	0.00
frontal lobe, adult, pool1	10040-101F4	12.76	0.56	0.28	0.56	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	9.91	8.71	3.90	1.80	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	14.54	4.02	1.55	1.01	0.00
gall bladder, adult	10198-103E9	46.36	5.07	0.97	0.72	0.72
gamma delta positive T cells, donor1	11937-126A2	20.40	4.29	0.00	2.68	0.54
gamma delta positive T cells, donor2	11938-126A3	18.30	5.23	0.00	2.99	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	10.35	2.32	1.06	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	7.35	3.29	0.77	0.77	0.00
gastric cancer cell line:AZ521	10549-107H9	8.20	9.02	6.39	1.97	0.00
gastric cancer cell line:GSS	10560-108A2	5.49	3.66	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	40.89	9.37	0.69	0.69	0.23
giant cell carcinoma cell line:LU65	10487-107B1	6.77	4.59	4.70	1.38	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	13.72	1.54	1.68	0.70	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	15.71	3.24	1.50	1.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	8.76	4.12	1.79	1.16	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	8.57	2.67	1.12	0.84	0.42
glioblastoma cell line:T98G	10485-107A8	30.90	8.39	2.43	2.43	0.55
glioma cell line:GI-1	10413-106B8	24.60	6.74	1.46	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	13.85	1.46	0.00	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	24.17	3.42	0.73	1.46	0.00
globus pallidus, adult, donor10258	10367-105F7	15.06	1.37	0.00	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	11.19	3.20	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	134.59	48.94	2.45	2.45	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	15.68	0.00	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	12.16	2.24	0.64	1.28	0.32
hIPS +CCl2, biol_rep1	14383-156B9	5.97	3.21	0.46	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	6.86	4.57	0.46	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	3.22	3.22	2.58	1.29	0.00
hIPS, biol_rep1	14380-156B6	2.87	5.75	1.44	1.44	0.00
hIPS, biol_rep2	14381-156B7	4.80	2.74	1.37	1.37	0.00
hIPS, biol_rep3	14382-156B8	0.00	1.10	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	21.26	7.47	2.01	4.88	0.29
heart - mitral valve, adult	10205-103F7	24.22	2.09	0.30	0.90	1.49
heart - pulmonic valve, adult	10206-103F8	36.08	2.35	0.52	2.61	1.05
heart - tricuspid valve, adult	10207-103F9	24.15	12.49	1.67	2.50	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	46.93	5.10	2.24	1.22	1.43
heart, adult, diseased, donor1	10051-101G6	96.66	3.41	2.55	0.43	1.70
heart, adult, pool1	10016-101C7	84.63	5.98	0.69	1.15	1.84
heart, fetal, pool1	10046-101G1	60.79	5.54	1.13	1.54	1.54
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.04	0.93	0.00	1.23	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	11.89	4.76	1.19	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	46.96	17.57	5.86	2.98	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	45.52	17.96	4.37	3.16	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	51.34	18.19	4.55	2.02	0.30
hepatoma cell line:Li-7	10484-107A7	13.79	10.68	3.23	1.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	25.23	9.65	1.51	2.01	0.30
hippocampus - adult, donor10196	10169-103B7	4.73	0.95	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	16.53	2.45	1.22	1.22	0.00
hippocampus, adult, donor10258	10374-105G5	1.99	0.50	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	4.58	1.06	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	7.32	12.21	3.05	3.05	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	15.90	11.00	3.53	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	13.46	14.22	3.81	2.03	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	9.02	2.82	1.69	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	12.65	6.46	2.84	1.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	14.05	7.21	3.80	1.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	11.09	7.88	4.09	0.88	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	13.79	7.11	1.94	1.08	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	10.43	7.92	1.25	1.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	13.97	5.68	1.89	0.47	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	18.96	6.59	2.09	1.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	18.18	6.73	4.71	2.02	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	15.49	12.52	2.82	1.25	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	10.32	8.35	1.97	0.98	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.11	10.47	3.49	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	15.27	4.58	1.91	0.76	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	10.90	3.49	1.31	2.18	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	7.00	5.50	2.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	7.91	1.51	1.13	1.13	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	5.00	2.73	0.45	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	6.58	1.88	1.25	1.25	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	9.31	2.94	0.82	0.98	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	9.00	2.61	0.58	0.58	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	7.17	2.99	0.30	0.90	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	14.78	7.76	4.25	0.92	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	14.55	9.13	1.43	1.14	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	13.47	10.21	4.49	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	12.32	2.46	2.82	1.06	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	7.92	4.75	1.58	1.58	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	8.47	6.05	2.12	0.91	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	6.72	3.62	0.52	1.03	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	9.96	4.65	1.99	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	8.47	3.85	1.54	1.28	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	12.78	4.35	1.79	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.12	2.27	3.79	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	11.09	6.39	1.01	1.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	20.05	8.21	2.17	0.97	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	9.36	9.36	3.12	2.67	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	11.71	6.83	3.41	1.46	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	10.09	3.67	3.06	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	9.76	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	6.62	7.28	1.99	3.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	13.68	3.28	1.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	7.60	5.43	3.62	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	7.12	3.91	0.71	1.07	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	8.35	5.97	5.97	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	13.00	4.33	2.30	1.08	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	6.47	4.31	1.35	0.81	0.27
immature langerhans cells, donor1	11904-125F5	12.59	7.02	0.48	0.97	0.97
immature langerhans cells, donor2	11905-125F6	14.26	9.51	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	14.86	1.23	0.47	1.32	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	15.93	5.20	0.98	1.30	0.65
kidney, adult, pool1	10017-101C8	69.19	6.61	3.40	1.40	1.00
kidney, fetal, pool1	10045-101F9	44.28	4.53	1.63	0.92	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	12.36	1.14	0.28	1.42	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	4.98	2.76	1.66	0.55	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	51.75	22.20	5.32	2.57	0.00
left atrium, adult, donor1	10079-102A7	50.67	5.45	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	73.32	3.54	0.00	1.01	1.01
leiomyoblastoma cell line:G-402	10721-110A1	6.84	5.47	2.19	0.55	0.27
leiomyoma cell line:10964C	10569-108B2	27.30	1.44	1.08	1.08	0.00
leiomyoma cell line:15242A	10570-108B3	15.22	1.09	1.09	0.00	0.00
leiomyoma cell line:15425	10571-108B4	16.75	3.16	1.21	1.21	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	10.46	9.41	3.14	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	20.07	2.83	0.71	1.18	0.24
liposarcoma cell line:KMLS-1	10782-110G8	16.71	2.34	1.09	0.47	0.31
liposarcoma cell line:SW 872	10726-110A6	23.03	9.02	2.44	2.68	0.24
liver, adult, pool1	10018-101C9	131.76	17.18	2.92	1.94	0.81
liver, fetal, pool1	10086-102B5	84.66	1.88	0.94	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	13.12	3.21	0.87	0.87	0.00
locus coeruleus, adult, donor10252	10165-103B3	19.38	2.58	0.92	1.29	0.18
locus coeruleus, adult, donor10258	10375-105G6	9.59	1.69	0.28	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	4.63	5.47	1.26	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	5.67	3.18	1.52	1.11	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	6.89	0.69	0.00	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	14.50	7.78	2.24	1.85	0.40
lung, adult, pool1	10019-101D1	31.19	6.73	0.83	1.30	0.35
lung, fetal, donor1	10068-101I5	21.98	3.14	0.57	0.57	1.14
lung, right lower lobe, adult, donor1	10075-102A3	31.16	5.50	1.37	1.37	0.46
lymph node, adult, donor1	10077-102A5	20.35	2.84	0.00	1.89	0.47
lymphangiectasia cell line:DS-1	10727-110A7	30.47	10.30	1.10	1.53	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	36.22	6.79	0.91	1.81	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	11.89	7.65	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	60.83	11.10	0.89	0.89	1.33
mature adipocyte, donor2	12232-129F9	41.09	4.57	0.42	0.83	1.25
mature adipocyte, donor3	12233-129G1	50.49	5.69	1.19	0.47	0.71
mature adipocyte, donor4	12234-129G2	55.01	4.47	1.05	1.32	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	5.72	0.71	0.71	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	1.13	1.13	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	15.26	2.21	0.55	1.47	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	6.04	0.95	0.32	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	2.13	0.00	0.00	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	10.63	1.69	0.17	1.18	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	21.22	2.12	1.70	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	5.38	1.44	0.36	1.44	0.00
medulla oblongata - adult, donor10196	10174-103C3	12.33	4.54	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	19.97	3.72	0.46	0.93	0.15
medulla oblongata, adult, pool1	10038-101F2	18.77	2.04	0.49	1.31	0.24
medulla oblongata, newborn, donor10223	10361-105F1	9.03	2.08	0.69	1.39	0.00
medulloblastoma cell line:D283 Med	10838-111E1	11.96	3.76	2.21	1.55	0.00
medulloblastoma cell line:ONS-76	10759-110E3	8.31	3.91	1.10	0.37	0.24
melanoma cell line:COLO 679	10514-107E1	5.89	2.44	0.14	1.15	0.14
melanoma cell line:G-361	10465-106H6	22.26	1.90	0.27	1.36	0.27
meningioma cell line:HKBMM	10691-109F7	12.30	2.53	0.54	1.63	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	24.67	16.74	2.64	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	34.74	13.48	3.37	3.37	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.63	4.91	1.69	1.23	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.54	2.73	0.36	1.09	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	9.11	4.97	2.07	1.66	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	16.30	4.35	0.84	1.26	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	17.52	3.47	0.58	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	22.90	2.08	0.00	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	18.19	2.57	1.20	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	22.08	4.37	1.04	0.58	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.19	4.64	0.66	1.59	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	19.04	10.67	1.76	1.49	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	13.66	6.54	1.71	1.42	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.87	3.95	3.62	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.38	7.06	0.97	1.25	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	10.47	4.89	1.05	2.44	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	9.39	3.88	0.41	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.86	2.88	1.08	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.17	4.14	0.41	0.93	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.26	2.96	0.46	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	12.17	5.03	0.84	2.10	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	11.96	5.38	0.60	0.60	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.12	6.21	1.23	1.14	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	9.57	3.31	1.47	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.30	4.29	0.57	1.43	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	16.84	7.58	2.95	2.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	18.72	1.83	1.37	1.37	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	13.56	1.79	0.51	0.77	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.13	1.57	1.83	0.79	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.71	2.77	1.23	0.92	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.47	1.65	0.24	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.51	0.34	1.35	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.58	3.93	0.00	1.57	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	3.71	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.42	3.17	2.88	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	15.39	2.01	1.34	0.89	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	16.34	3.12	1.20	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.93	2.20	1.47	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.40	2.69	1.01	1.01	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.51	1.23	1.23	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	10.31	1.72	0.86	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	2.73	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	17.54	3.90	0.97	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	2.91	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	12.26	2.67	0.53	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	14.72	3.27	0.00	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	10.11	1.17	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	8.94	2.98	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	12.45	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	15.84	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.13	2.53	1.90	3.17	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.80	1.38	1.38	0.00	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	0.00	0.00	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	3.44	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	18.34	0.81	0.81	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.09	1.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.33	1.18	1.18	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	18.08	3.43	0.31	0.94	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	1.34	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	15.37	2.37	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	2.57	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	18.59	2.07	0.69	0.69	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	40.08	6.43	1.98	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	22.43	1.12	3.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	30.53	5.72	3.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	48.76	8.06	3.22	1.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	34.89	6.54	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	41.81	8.87	2.53	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	35.20	1.82	1.21	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	4.52	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	29.65	6.59	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	18.65	1.19	0.20	0.79	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	18.82	3.57	0.32	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	19.35	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	13.93	2.32	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	18.66	4.72	1.65	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	26.41	4.87	1.39	1.39	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	8.55	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.96	3.39	0.62	0.31	0.10
mesothelioma cell line:Mero-25	10850-111F4	23.83	6.35	1.13	0.91	0.00
mesothelioma cell line:Mero-41	10851-111F5	11.73	1.71	0.73	1.96	0.00
mesothelioma cell line:Mero-48a	10852-111F6	7.75	3.76	0.66	1.11	0.00
mesothelioma cell line:Mero-82	10853-111F7	20.50	4.99	0.26	0.79	0.26
mesothelioma cell line:Mero-83	10854-111F8	9.36	3.74	0.51	1.19	0.17
mesothelioma cell line:Mero-84	10855-111F9	9.35	4.80	0.51	2.02	0.25
mesothelioma cell line:Mero-95	10856-111G1	12.84	2.69	1.24	0.41	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	18.06	10.93	4.47	2.48	0.17
mesothelioma cell line:NCI-H226	10846-111E9	6.70	5.07	1.81	1.63	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	11.27	6.32	3.76	0.68	0.17
mesothelioma cell line:NCI-H28	10845-111E8	17.30	11.45	3.82	0.51	0.51
mesothelioma cell line:No36	10857-111G2	6.85	3.59	4.24	1.63	0.65
mesothelioma cell line:ONE58	10858-111G3	15.44	2.17	1.08	0.81	0.27
migratory langerhans cells, donor1	11901-125F2	11.32	6.72	3.45	1.54	0.58
migratory langerhans cells, donor2	11902-125F3	15.63	6.96	1.34	1.83	0.49
migratory langerhans cells, donor3	11903-125F4	16.51	4.85	3.05	2.15	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	9.79	6.20	0.65	0.33	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	10.60	3.60	1.70	0.85	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	7.37	5.30	2.07	1.15	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	21.12	7.04	0.95	3.04	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	23.47	10.35	2.59	2.22	0.74
myeloma cell line:PCM6	10474-106I6	9.69	1.38	0.40	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	15.73	5.07	1.01	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	16.08	12.16	3.92	1.18	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.57	2.34	0.56	0.33	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	6.77	2.87	0.88	0.22	0.00
nasal epithelial cells, donor2	12227-129F4	14.35	1.10	1.10	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	15.18	1.84	1.38	0.92	0.23
neuroblastoma cell line:NB-1	10539-107G8	24.13	8.98	3.55	4.68	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	11.81	2.53	0.21	0.84	0.00
neuroblastoma cell line:NH-12	10555-107I6	14.35	6.15	1.30	0.93	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	9.73	3.80	1.90	1.90	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	13.94	3.96	0.48	0.79	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	15.90	6.44	1.01	1.41	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	15.89	5.72	0.00	3.18	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	14.91	0.80	0.80	1.06	0.00
neutrophil PMN, donor1	12133-128D9	208.25	59.50	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	39.84	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	56.49	8.46	0.85	5.75	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	13.61	1.60	1.60	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	20.20	2.56	1.60	0.96	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	21.81	2.89	1.31	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	13.69	1.31	0.19	1.31	0.28
occipital cortex - adult, donor10196	10172-103C1	6.18	0.00	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	16.10	3.22	1.34	1.61	0.00
occipital cortex, newborn, donor10223	10355-105E4	8.37	4.73	0.73	1.82	0.00
occipital lobe, adult, donor1	10076-102A4	12.60	1.57	0.26	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	20.17	1.72	1.29	1.72	0.43
occipital pole, adult, pool1	10036-101E9	15.06	1.73	0.47	1.58	0.32
olfactory region, adult	10195-103E6	12.99	1.15	0.38	0.57	0.00
optic nerve, donor1	10277-104E7	18.01	2.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	14.81	3.19	1.37	0.80	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	20.88	3.02	1.92	0.82	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	22.18	8.64	2.20	2.03	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	10.86	5.66	0.69	0.81	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	8.23	2.06	1.47	0.88	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	9.34	4.67	1.87	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	27.14	5.94	2.12	0.85	0.00
ovary, adult, pool1	10020-101D2	22.80	2.01	1.05	0.87	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	20.17	7.52	4.03	1.28	0.73
pancreas, adult, donor1	10049-101G4	56.44	9.41	4.70	3.76	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	4.75	3.63	1.12	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	15.67	4.94	1.36	0.17	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	18.88	6.79	1.66	1.16	0.83
paracentral gyrus, adult, pool1	10035-101E8	11.71	1.19	0.27	1.83	0.27
parietal cortex, adult, donor10258	10373-105G4	5.87	0.73	0.00	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	13.17	1.88	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	13.97	2.28	0.00	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	15.24	1.50	0.44	0.70	0.09
parietal lobe, fetal, donor1	10072-101I9	15.52	1.94	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	5.98	1.50	0.00	1.12	0.00
parotid gland, adult	10199-103F1	18.50	4.32	0.00	0.62	1.23
penis, adult	10200-103F2	32.23	2.69	1.07	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	8.92	3.16	0.56	0.56	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	28.41	5.10	1.17	1.17	0.44
pineal gland - adult, donor10196	10179-103C8	8.39	1.29	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	14.21	2.37	1.18	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	8.15	1.88	0.63	1.88	0.00
pituitary gland - adult, donor10196	10180-103C9	6.07	3.04	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	13.03	2.61	1.56	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	11.92	4.26	0.00	0.85	0.00
placenta, adult, pool1	10021-101D3	20.96	5.16	1.51	0.97	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	14.83	5.16	0.66	3.18	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.92	2.49	0.62	0.47	0.16
pons, adult, pool1	10033-101E6	13.94	1.38	0.86	1.12	0.43
postcentral gyrus, adult, pool1	10032-101E5	12.81	1.57	0.61	0.78	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	112.94	20.91	0.00	4.18	10.46
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	23.47	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	13.69	7.14	4.52	2.48	0.29
prostate cancer cell line:PC-3	10439-106E7	18.88	4.17	1.63	0.54	0.36
prostate, adult, pool1	10022-101D4	25.76	2.09	0.91	0.45	0.18
putamen, adult, donor10196	10176-103C5	12.28	1.42	0.47	0.24	0.00
putamen, adult, donor10252	10152-102I8	13.73	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	9.42	0.48	0.00	0.97	0.24
putamen, newborn, donor10223	10365-105F5	1.50	0.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	12.51	4.36	0.87	1.45	0.00
rectum, fetal, donor1	10067-101I4	73.72	6.95	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	19.72	12.93	4.24	1.70	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	18.64	1.66	1.66	0.83	0.00
retina, adult, pool1	10030-101E3	26.84	2.09	0.50	1.99	0.40
retinoblastoma cell line:Y79	10475-106I7	17.93	3.64	4.16	1.82	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.82	6.27	2.46	1.11	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	17.43	5.91	4.50	0.28	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	24.25	2.27	0.76	0.00	0.76
salivary acinar cells, donor1	11771-123I7	14.08	1.94	0.32	1.13	0.49
salivary acinar cells, donor2	11772-123I8	15.42	0.83	0.14	0.55	0.41
salivary acinar cells, donor3	11773-123I9	17.21	0.66	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	22.31	5.15	1.72	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	4.72	4.81	1.18	0.51	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	4.70	2.94	2.82	0.00	0.00
seminal vesicle, adult	10201-103F3	20.10	1.59	0.53	1.59	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	24.29	5.59	1.94	1.21	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	9.81	3.27	0.00	2.01	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	12.04	5.02	3.01	4.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	24.85	10.07	4.16	1.48	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	14.81	5.31	1.88	0.44	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	37.68	7.87	2.84	2.06	1.68
skeletal muscle - soleus muscle, donor1	10282-104F3	28.37	0.71	0.00	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	55.17	6.60	2.28	0.84	0.48
skeletal muscle, fetal, donor1	10066-101I3	20.10	3.02	1.01	1.01	1.01
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	23.36	2.52	0.00	0.63	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	40.36	8.00	0.67	1.67	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	5.36	5.99	1.58	1.89	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	11.18	3.47	2.89	1.93	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	12.86	1.65	0.33	1.48	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	11.10	3.54	3.06	0.64	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	11.77	6.10	0.87	1.31	0.22
small intestine, adult, pool1	10024-101D6	182.03	14.57	3.58	1.55	2.39
small intestine, fetal, donor1	10064-101I1	60.69	7.62	1.23	1.47	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	35.90	3.08	1.03	2.05	1.03
smooth muscle, adult, pool1	10048-101G3	29.46	2.07	0.26	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	7.50	1.88	0.27	1.07	0.27
spinal cord - adult, donor10196	10181-103D1	14.91	1.61	0.46	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	16.56	2.76	1.97	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	3.46	0.00	0.00	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	27.44	3.05	1.22	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	4.59	3.21	1.38	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	12.70	3.29	1.19	1.49	0.15
spleen, adult, pool1	10025-101D7	29.74	6.61	0.44	1.54	0.77
spleen, fetal, pool1	10044-101F8	29.56	8.50	1.11	2.07	0.95
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	14.49	2.79	0.83	1.14	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	14.43	4.56	0.95	0.76	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	20.97	4.89	2.80	0.70	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	13.68	3.91	1.56	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	11.82	4.05	1.35	0.68	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	14.83	2.12	0.00	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	9.31	8.46	3.38	1.27	0.00
stomach, fetal, donor1	10062-101H8	67.28	5.34	1.07	2.14	3.20
submaxillary gland, adult	10202-103F4	22.79	4.56	0.57	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	22.43	4.15	0.42	0.42	0.21
substantia nigra, adult, donor10258	10371-105G2	4.14	0.52	1.03	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	8.48	2.83	0.00	2.83	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	30.72	5.96	3.67	1.83	1.38
temporal lobe, adult, pool1	10031-101E4	17.46	1.53	0.34	1.61	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	16.38	2.85	0.71	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	11.43	2.20	0.44	0.88	0.44
tenocyte, donor1	11763-123H8	34.56	4.54	2.09	0.70	0.70
tenocyte, donor2	11765-123I1	14.50	2.29	0.38	0.76	0.38
tenocyte, donor3	11768-123I4	17.05	4.08	1.11	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	13.09	6.63	1.53	0.51	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	21.89	8.32	1.23	1.54	0.31
teratocarcinoma cell line:PA-1	10807-111A6	13.64	4.18	2.32	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	10.92	6.09	1.40	1.14	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	8.32	5.29	1.13	1.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	9.05	5.23	0.76	0.33	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	20.84	2.28	0.65	1.63	0.33
testis, adult, pool1	10026-101D8	31.25	3.87	1.83	2.15	0.00
testis, adult, pool2	10096-102C6	27.97	4.51	3.16	5.41	0.00
thalamus - adult, donor10196	10168-103B6	17.66	3.31	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	17.50	2.34	0.16	0.78	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	4.62	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.54	1.48	0.82	0.66	0.49
thalamus, newborn, donor10223	10366-105F6	2.30	0.58	0.58	0.58	0.00
throat, adult	10209-103G2	36.45	2.50	2.25	1.25	1.00
throat, fetal, donor1	10061-101H7	26.20	4.57	0.61	1.52	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	21.26	3.58	2.58	1.79	0.60
thymus, adult, pool1	10027-101D9	20.98	10.64	1.19	6.26	0.30
thymus, fetal, pool1	10043-101F7	16.83	10.18	0.94	3.43	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	19.94	10.37	3.32	1.99	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	16.06	6.43	3.07	1.12	0.42
thyroid, adult, pool1	10028-101E1	25.94	3.83	1.68	1.12	0.56
thyroid, fetal, donor1	10060-101H6	23.99	2.11	0.26	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	28.14	3.49	0.00	2.09	1.16
tongue, fetal, donor1	10059-101H5	39.41	4.73	0.39	1.97	0.00
tonsil, adult, pool1	10047-101G2	33.66	7.61	1.40	2.40	0.90
trachea, adult, pool1	10029-101E2	18.40	5.97	1.55	0.98	0.49
trachea, fetal, donor1	10058-101H4	21.93	5.00	0.38	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	21.26	5.31	0.71	1.06	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	17.63	6.18	1.93	1.72	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	11.59	5.33	2.19	0.94	0.31
tridermal teratoma cell line:HGRT	10694-109G1	9.51	3.81	5.71	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	25.56	5.33	1.86	0.42	0.59
umbilical cord, fetal, donor1	10057-101H3	31.30	4.17	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	16.72	3.24	1.71	0.68	0.34
uterus, fetal, donor1	10055-101H1	20.48	1.54	2.56	2.05	0.51
vagina, adult	10204-103F6	15.51	2.58	0.65	0.00	0.65
vein, adult	10191-103E2	26.30	5.26	0.66	3.51	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.89	7.21	1.34	1.34	0.27